Search by Drug Name or NDC
NDC 00013-1114-21 Cyklokapron 100 mg/mL Details
Cyklokapron 100 mg/mL
Cyklokapron is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is TRANEXAMIC ACID.
Product Information
| NDC | 00013-1114 |
|---|---|
| Product ID | 0013-1114_6203322e-0dd7-4d18-be4a-4501357b0a5f |
| Associated GPIs | 84100040002025 |
| GCN Sequence Number | 070001 |
| GCN Sequence Number Description | tranexamic acid AMPUL 1000 MG/10 INTRAVEN |
| HIC3 | M9D |
| HIC3 Description | ANTIFIBRINOLYTIC AGENTS |
| GCN | 33285 |
| HICL Sequence Number | 002802 |
| HICL Sequence Number Description | TRANEXAMIC ACID |
| Brand/Generic | Brand |
| Proprietary Name | Cyklokapron |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tranexamic acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | TRANEXAMIC ACID |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019281 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00013-1114-21 (00013111421)
| NDC Package Code | 0013-1114-21 |
|---|---|
| Billing NDC | 00013111421 |
| Package | 10 VIAL in 1 BOX (0013-1114-21) / 10 mL in 1 VIAL (0013-1114-20) |
| Marketing Start Date | 1986-12-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |